CINRYZE® (C1 esterase inhibitor [human]) is an injectable prescription medicine that is used to help prevent swelling and/or painful attacks in children (6 years of age and older), teenagers and adults with Hereditary Angioedema (HAE).
![CINRYZE® (C1 esterase inhibitor [human]) Logo](/dist/images/hdr-logo2.webp){kind=logo}
CINRYZE Resources
Not real patients.
Doctor Discussion Guide
Download and complete this questionnaire with you or your child's information to share with your doctor and start a conversation about preventive treatment.
Download & print the Doctor Discussion Guide
CINRYZE Power of Prevention brochure
This overview of CINRYZE can help you understand how CINRYZE works, the role of preventive therapy in HAE, and what to expect from therapy.
HAE Family Health Tree worksheet
Track your family history of HAE with the HAE Family Health Tree worksheet. Download and print a PDF to share with your doctor and family members to help them understand how HAE can affect the whole family.
Path to Independence™ brochure
Find out about self-administration training for eligible patients, as well as other resources available to you through the Takeda Patient Support one-on-one product support program.
HAE Attack Plan letter
Personalize this letter with your medical information and share it with the people in your life who need to know what to do if you have an HAE attack.
Caring for Someone with HAE
Find helpful information and resources to help support a loved one with HAE and learn about the important role of being a caregiver.
CINRYZE Self-Administration Instructions
Keep these illustrated, step-by-step instructions close by to help you self-administer CINRYZE therapy. This guide is designed to provide additional support after a healthcare professional has taught you how to self-administer.
Takeda advises that you or a caregiver receive training from a healthcare professional prior to self-administration.
Want to keep exploring?
See how to get started with Patient Support and learn about the
product support services available for eligible patients.
Learn more
You might also be interested in:
